Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered wit...
Q2 2026
Aug 6, 2026
Q1 2026
May 5, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 5, 2025